Follow
OncoZenge AB
Nasdaq First North GM (Sweden)
OncoZenge AB is a pharmaceutical company. It focuses on improving the quality of life for patients with severe oral pain caused by radiation therapy or chemotherapy for cancer.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ONCOZ
SE0015504097
Nasdaq First North GM
Sweden (SE)
Details of share in OncoZenge AB with ticker ONCOZ
Status
Active
Order book id
216185
Amount of instruments
5 856 622
Par value
Currency
SEK
Segment
First North
Type
Price
Pre-money valuation
Time
Files
Listing
60.03M SEK
12 Feb 2021
Direct listing of OncoZenge AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Rights issue
10.25 SEK
60.03M SEK
19 Feb - 05 Mar 2021
Share issue in OncoZenge AB
People
Pirkko Tamsen
CEO
Anna Ljung
Chairman of the board
Mattias Klintemar
Board member
Torben Mogensen
Board member
Hilde Furberg
Board member
Company Details
Sector
HEALTH CARE

Address
Gustavslundsvägen 34
Zip code
167 51
City/district
Bromma
Country
Sweden (SE)
Registration number
559261-9968
LEI code
2549003980RBCR6NIF38
First trade date
12 Feb 2021
Registration date
02 Jul 2020
Short name
OncoZenge

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More